1. Post-autologous Transplant Therapy for Hodgkin Lymphoma

3. Program Goals

4. cHL Overview

5. cHL Poor Prognosis Risk Factors

6. Case Study 1 45-Year-Old Man With Early-Stage cHL

7. Post-HDT/ASCT BV Maintenance Phase 3 AETHERA Trial Design

8. Phase 3 AETHERA Trial Efficacy Data

9. Phase 3 AETHERA Trial Safety Data

10. Case Study 2 22-Year-Old Woman With Early-Stage cHL

11. Case Study 2 Treatment Options

12. Case Study 3 43-Year-Old Woman With Bulky cHL

13. Case Study 3 Treatment Options

14. Relapsed/Refractory cHL Moving Toward New Paradigm

15. Abbreviations

16. Abbreviations (cont)

17. References

18. References (cont)

19. References (cont)

20. References (cont)

21. References (cont)